You are here:
Home
NICE Guidance
Health and social care delivery
Emergency care
CytoSorb for reducing risk of bleeding during cardiac surgery
Medtech innovation briefing
Reference number:
MIB249
Published:
02 February 2021
Download (PDF)
Overview
Summary
The technology
Regulatory information
Equality considerations
Clinical and technical evidence
Expert comments
Expert commentators
Development of this briefing
Regulatory information
CytoSorb is a CE‑marked class IIb medical device.
Next page
Equality considerations
Previous page
The technology